Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis

被引:42
作者
Abs, Roger [1 ]
Mattsson, Anders F. [2 ]
Thunander, Maria [3 ]
Verhelst, Johan [4 ]
Goth, Miklos I. [5 ]
Wilton, Patrick [2 ]
Koltowska-Haggstrom, Maria [2 ]
Luger, Anton [6 ]
机构
[1] Antwerp Ctr Endocrinol, B-2600 Antwerp, Belgium
[2] Pfizer Inc, Endocrine Care, SE-19190 Sollentuna, Sweden
[3] Lund Univ, Cent Hosp, SE-19190 Sollentuna, Sweden
[4] ZNA Middelheim, Dept Endocrinol, B-2020 Antwerp, Belgium
[5] Mil Hosp, State Hlth Ctr, HU-1062 Budapest, Hungary
[6] Med Univ Vienna, Clin Div Endocrinol & Metab, A-1090 Vienna, Austria
关键词
BODY-MASS INDEX; GROWTH-FACTOR-I; CLINICAL CHARACTERISTICS; WAIST CIRCUMFERENCE; HORMONE; GLUCOSE; HYPOGLYCEMIA; POPULATION; METABOLISM; DATABASE;
D O I
10.1530/EJE-12-0807
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Design and methods: Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values < 0.05 were considered statistically significant. Results: PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. Conclusions: GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. European Journal of Endocrinology 168 297-305
引用
收藏
页码:297 / 305
页数:9
相关论文
共 30 条
[1]
Isolated growth hormone (GH) deficiency in adult patients:: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients.: A sub-analysis of the KIMS database [J].
Abs, R ;
Mattsson, AF ;
Bengtsson, BÅ ;
Feldt-Rasmussen, U ;
Góth, MI ;
Koltowska-Häggström, M ;
Monson, JP ;
Verhelst, J ;
Wilton, P .
GROWTH HORMONE & IGF RESEARCH, 2005, 15 (05) :349-359
[2]
GH replacement in 1034 growth hormone deficient hypopituitary adults:: demographic and clinical characteristics, dosing and safety [J].
Abs, R ;
Bengtsson, BÅ ;
Hernberg-Ståhl, E ;
Monson, JP ;
Tauber, JP ;
Wilton, P ;
Wüster, C .
CLINICAL ENDOCRINOLOGY, 1999, 50 (06) :703-713
[3]
[Anonymous], 2012, GLOB GUID TYP 2 DIAB, p[9, 9]
[4]
Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: A Surveillance Database Analysis [J].
Attanasio, Andrea F. ;
Jung, Heike ;
Mo, Daojun ;
Chanson, Philippe ;
Bouillon, Roger ;
Ho, Ken K. Y. ;
Lamberts, Steven W. J. ;
Clemmons, David R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) :2255-2261
[5]
HbA1c as a screening tool for detection of Type 2 diabetes:: a systematic review [J].
Bennett, C. M. ;
Guo, M. ;
Dharmage, S. C. .
DIABETIC MEDICINE, 2007, 24 (04) :333-343
[6]
BETA-CELL FUNCTION IN HYPOPITUITARY ADULTS BEFORE AND DURING GROWTH-HORMONE TREATMENT [J].
BESHYAH, SA ;
GELDING, SV ;
ANDRES, C ;
JOHNSTON, DG ;
GRAY, IP .
CLINICAL SCIENCE, 1995, 89 (03) :321-328
[7]
EFFECTS OF HYPOPITUITARISM AND GROWTH-HORMONE REPLACEMENT THERAPY ON THE PRODUCTION AND UTILIZATION OF GLUCOSE IN CHILDHOOD [J].
BOUGNERES, PF ;
ARTAVIALORIA, E ;
FERRE, P ;
CHAUSSAIN, JL ;
JOB, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1152-1157
[8]
GROWTH-HORMONE, CORTISOL, OR BOTH ARE INVOLVED IN DEFENSE AGAINST, BUT ARE NOT CRITICAL TO RECOVERY FROM, HYPOGLYCEMIA [J].
BOYLE, PJ ;
CRYER, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :E395-E402
[9]
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].
Brabant, G ;
von zur Mühlen, A ;
Wüster, C ;
Ranke, MB ;
Kratzsch, J ;
Kiess, W ;
Ketelslegers, JM ;
Wilhelmsen, L ;
Hulthén, L ;
Saller, B ;
Mattsson, A ;
Wilde, J ;
Schemer, R ;
Kann, P .
HORMONE RESEARCH, 2003, 60 (02) :53-60
[10]
Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism [J].
Cordido, F ;
Fernandez, T ;
Martinez, T ;
Peñalva, A ;
Peinó, R ;
Casanueva, FF ;
Dieguez, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4350-4354